New drug shows promise for managing short bowel syndrome Long-Term
NCT ID NCT07228403
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at the long-term safety and effectiveness of a drug called glepaglutide in adults with short bowel syndrome (SBS), a condition where the body can't absorb enough nutrients from food. Participants who were already in earlier trials can continue treatment for up to 2 years. The goal is to see if the drug helps reduce the need for intravenous nutrition support and is safe over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SHORT BOWEL SYNDROME (SBS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AP-HP - Hôpital Beaujon
Clichy, Hauts-de-Seine, 92118, France
-
Asklepios Klinik St. Georg
Hamburg, 20099, Germany
-
Charité - Universitätsmedizin Berlin
Berlin, State of Berlin, 10117, Germany
-
Cleveland Clinic-9500 Euclid Ave
Cleveland, Ohio, 44195-0001, United States
-
LHSC - University Hospital
London, Ontario, N6A 4V2, Canada
-
Lied Transplant Center at Nebraska Medical Center
Omaha, Nebraska, 68105, United States
-
Mayo Clinic - PPDS
Rochester, Minnesota, 55905-0001, United States
-
Samodzielny Publiczny Szpitala Kliniczny im. Prof. Witolda Orlowskiego CMKP
Warsaw, Masovian Voivodeship, 00-416, Poland
-
St Mark's Hospital (Central Middlesex Hospital)
Ealing, NW10 7NS, United Kingdom
-
Szpital Skawina sp. z o.o. im. Stanley Dudricka
Skawina, Lesser Poland Voivodeship, 32-050, Poland
-
UZ Leuven - PPDS
Leuven, 3000, Belgium
-
Universitätsklinikum Bonn
Bonn, North Rhine-Westphalia, 53127, Germany
-
Universitätsklinikum Frankfurt
Frankfurt am Main, Hesse, 60590, Germany
-
Universitätsmedizin Rostock
Rostock, Mecklenburg-Vorpommern, 18057, Germany
-
Vanderbilt University Medical Center-Tennesse-1211 21st Ave S
Nashville, Tennessee, 37212-2700, United States
-
Wojewódzki Szpital Specjalistycznyo im. M. Pirogowa w Lodzi
Lodz, 90-531, Poland